2017 War on Skin Cancer Scientific Symposium

An OHSU doctor converses with a woman in front of a window

Continuing Medical Education

Saturday, May 20, 2017, 8:30 a.m. - 3:15 p.m.

Collaborative Life Sciences Building
Portland, Ore.

This one-day course is designed for general practitioners, dermatologists, cancer care providers and researchers. OHSU Knight Cancer Institute physicians and expert guest speakers, including keynote speaker, Dr. Jedd Wolchok from Memorial Sloan Kettering Cancer Center in New York, will provide an overview of the latest advances in the prevention, risk and genetics and local and systemic treatment of melanoma.

At the conclusion of the course, participants will be able to:
  1. Describe the immunologic basis of melanoma immunotherapy.
  2. Describe common immune adverse events and how to treat them.
  3. Discuss the role of molecular aberrations in melanoma and how they are used clinically.
  4. Discuss the pros and cons of regional therapy options for melanoma.
  5. Describe treatment options for uveal melanoma.
  6. Describe treatment options for melanoma brain metastases.
  7. Describe the epidemiology of melanoma and how to best prevent melanoma.
  8. Discuss hereditary melanoma and who should be referred for genetic testing.
  9. Describe which patients are appropriate for Mohs surgery for melanoma.

Course is free for all medical professionals and is designated for a maximum of 5.25 AMA PRA Category 1 Credits™. For more information, please call 503-494-0433 or email aronstei@ohsu.edu.

Download program brochure

Space is limited,
register soon!


The symposium is part of the annual War on Skin Cancer event to put an end to skin cancer as we know it. Family and community members are invited to a variety of events on the same day.


OHSU Knight Cancer Institute faculty

Pamela Cassidy, Ph.D.
Research associate professor

Jeremy Ciporen, M.D.
Assistant professor, neurosurgery

Tracy Funk, M.D.
Assistant professor, dermatology

Sancy Leachman, M.D, Ph.D.
Professor and chair of dermatology

Justin Leitenberger, M.D.
Assistant professor, dermatology

Amanda Lund, Ph.D.
Assistant professor, dermatology

Kristen Massimino, M.D.
Associate professor, surgical oncology

Jone Sampson, M.D.
Clinical associate professor, genetics

Alison Skalet, M.D., Ph.D.
Assistant professor, ophthalmology

Matthew Taylor, M.D.
Assistant professor, hematology oncology

John Vetto, M.D.
Professor, surgical oncology

Oliver Wisco, D.O.
Assistant professor, dermatology

Missy Wong, Ph.D.
Associate professor, cell, developmental and cancer biology

Guest faculty

Jedd Wolchok, M.D., Ph.D.
Medical oncologist, Memorial Sloan Kettering Cancer Center, New York, N.Y.

Brendan Curti, M.D.

Medical oncologist; co-director, melanoma program, Providence Health & Services, Portland, Ore.



Saturday, May 20, 2017

8:30 a.m.         Registration and breakfast

9 a.m.              Introductory remarks
Sancy Leachman, M.D., Ph.D., Kristen Massimino, M.D.

Session 1 – Systemic Therapy for Melanoma

9:10 a.m.          Biologic basis of immunotherapy
Matthew Taylor, M.D.

9:20 a.m.         Checkpoint blockade
Matthew Taylor, M.D.

9:30 a.m.         Unwanted effects of immunotherapy
Brendan Curti, M.D.

9:40 a.m.         Vaccines in the treatment of melanoma
Brendan Curti, M.D.

9:50 a.m.         Tumor board, panel Q&A

10:10 a.m.        Break

10:30 a.m.        Keynote Speaker: Jedd Wolchok, M.D., Ph.D.

11:30 a.m.       Lunch, panel discussion on hot topics for patients

Session 2 – Prevention, Risk and Genetics

12:30 p.m.       Epidemiology
Pam Cassidy, Ph.D.

12:40 p.m.       Sun protection 101
Tracy Funk, M.D.

12:50 p.m.       Melanoma biomarkers
Melissa Wong, Ph.D.

1 p.m.              Gene expression profile tests
Sancy Leachman, M.D., Ph.D.

1:10 p.m.         Genetic testing for melanoma
Jone Sampson, M.D.

1:20 p.m.         Tumor board, panel Q&A

1:30 p.m.         Break

Session 3 – Local Therapy for Melanoma

1:45 p.m.         Current approaches to uveal melanoma diagnosis and treatment
Alison Skalet, M.D., Ph.D.

1:55 p.m.         Mohs for melanoma
Justin Leitenberger, M.D.

2:05 p.m.         Excise or refer?
Oliver Wisco, D.O.

2:15 p.m.         Tumor microenvironment: the role of lymphatics
Amanda Lund, Ph.D.

2:25 p.m.         Evolution of lymph node management in melanoma
John Vetto, M.D.

2:35 p.m.         Regional therapy for melanoma: resect, inject or infuse?
Kristen Massimino, M.D.

2:45 p.m.         Central nervous system metastases
Jeremy Ciporen, M.D.

2:55 p.m.         Tumor board, Q&A

3:15 p.m.         Adjourn


Credit Statement


Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


OHSU School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration and Contact


Registration includes lunch on Saturday, May 20 and all course materials. Early registration is encouraged, as enrollment is limited.


For more information, please call 503-494-0433 or email .

Request reasonable accommodation for this event at 503-494-2834 or .